Bringing Bioprocess Development into Focus: More collaboration and a knowledge-based approach, driven by better analytics and high-throughput system integration, are reducing the risk of failure.

Detalles Bibliográficos
Publicado en:Pharmaceutical Technology Vol. 44; no. 11; pp. 16 - 19
Autor principal: Shanley, Agnes
Formato: Journal Article
Publicado: MJH Life Sciences Nov2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=147009578&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 147009578
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15432521
        4FK
      jtl: Pharmaceutical Technology
      issn: 15432521
      maglogo: N
    pubinfo:
      dt: Nov2020
      vid: 44
      iid: 11
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        147009578
        147009578
      ppf: 16
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Bringing Bioprocess Development into Focus: More collaboration and a knowledge-based approach, driven by better analytics and high-throughput system integration, are reducing the risk of failure.
      aug:
        au: Shanley, Agnes
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N